This is a routine administrative filing with no trading implications. Monitor for future filings that may contain clinical trial results, financial reports, or capital raises, which are the primary catalysts for this development-stage biotech.
Price Chart
Executive Summary
Alterity Therapeutics filed a Form 6-K on August 14, 2026, solely to submit an exhibit (Exhibit 99.1) for an 'Application for quotation of securities - ATH'. The filing contains no financial data, no business updates, no clinical trial results, and no material corporate events. This is a routine administrative filing related to the quotation of the company's securities on the Australian Securities Exchange (ASX).
Key Facts
- Filed a Form 6-K on August 14, 2026.
- The sole exhibit is an 'Application for quotation of securities - ATH' (Exhibit 99.1).
- No financial results, business updates, or material events were disclosed in the filing.
Financial Impact
No financial impact from this filing.
Risk Factors
- No new information was provided; the stock may continue to trade on existing news flow.
- As a development-stage enterprise, the company has no revenue and is dependent on future financing and clinical trial outcomes.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001437749-26-027814 |
| Document: 0001437749-26-027814-index-headers.html | 0001437749-26-027814 |
| Document: 0001437749-26-027814-index.html | 0001437749-26-027814 |
| Document: 0001437749-26-027814.txt | 0001437749-26-027814 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.06 (+1.44%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.06 (−1.44%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.06 (−1.44%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.06 (−13.81%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.06 (−13.81%) |
Oct 19, 2026 8d ago | 6-K | $2.43 | awaiting T+60 | — | $2.06 (−15.23%) |
Oct 9, 2026 18d ago | 6-K | $3.12 | awaiting T+60 | — | $2.06 (−33.97%) |
Oct 5, 2026 22d ago | Press Release | $3.22 | awaiting T+60 | — | $2.06 (−36.02%) |
Oct 5, 2026 22d ago | 6-K | $3.22 | awaiting T+60 | — | $2.06 (−36.02%) |
Sep 25, 2026 4w ago | 6-K | $3.67 | awaiting T+60 | — | $2.06 (−43.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers